ACIDE ZOLEDRONIQUE TILLOMED 4 mg/5 mL, solution à diluer pour perfusion — 1 flacon(s) en verre de 5 ml
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400930217450 -
CIP7
3021745 -
CIS
69694737
What the source publishes
- Holder
- TILLOMED PHARMA (ALLEMAGNE)
- Active ingredients
- ACIDE ZOLÉDRONIQUE ANHYDRE, ACIDE ZOLÉDRONIQUE MONOHYDRATÉ
- Form
- solution à diluer pour perfusion
- Package
- 1 flacon(s) en verre de 5 ml
- Routes
- intraveineuse
- Administrative status
- authorised
- Supply regime
- médicament nécessitant une surveillance particulière pendant le traitement ; liste I
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 2020-11-06
- Prescription
- Prescription or restricted
Names this record is found by
- ACIDE ZOLEDRONIQUE TILLOMED 4 mg/5 mL, solution à diluer pour perfusion — 1 flacon(s) en verre de 5 ml
- ACIDE ZOLEDRONIQUE TILLOMED 4 mg/5 mL, solution à diluer pour perfusion
- ACIDE ZOLÉDRONIQUE ANHYDRE
- ACIDE ZOLÉDRONIQUE MONOHYDRATÉ
Complete source data
{
"cis": "69694737",
"cip7": "3021745",
"form": "solution à diluer pour perfusion",
"name": "ACIDE ZOLEDRONIQUE TILLOMED 4 mg/5 mL, solution à diluer pour perfusion — 1 flacon(s) en verre de 5 ml",
"cip13": "3400930217450",
"holder": "TILLOMED PHARMA (ALLEMAGNE)",
"routes": [
"intraveineuse"
],
"holders": [
"TILLOMED PHARMA (ALLEMAGNE)"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": "116.55",
"authorisedOn": "2020-11-06",
"compositions": [
{
"name": "ACIDE ZOLÉDRONIQUE ANHYDRE",
"nature": "FT",
"strength": "4 mg",
"linkageNumber": "1",
"substanceCode": "41881",
"dosageReference": "5 mL de solution à diluer",
"pharmaceuticalElement": "solution"
},
{
"name": "ACIDE ZOLÉDRONIQUE MONOHYDRATÉ",
"nature": "SA",
"strength": "4,264 mg",
"linkageNumber": "1",
"substanceCode": "98588",
"dosageReference": "5 mL de solution à diluer",
"pharmaceuticalElement": "solution"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "médicament nécessitant une surveillance particulière pendant le traitement ; liste I",
"dispensingFee": "1.02",
"medicinePrice": "115.53",
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "ACIDE ZOLEDRONIQUE TILLOMED 4 mg/5 mL, solution à diluer pour perfusion",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-11-20",
"CIS_CIP_bdpm": "2026-11-20",
"CIS_CPD_bdpm": "2026-11-20",
"CIS_COMPO_bdpm": "2026-11-20"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "1 flacon(s) en verre de 5 ml",
"patientEligibility": "not-assessed",
"reimbursementRates": [
"65 %"
],
"marketingDeclaredOn": "2025-06-06",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"ACIDE ZOLÉDRONIQUE ANHYDRE",
"ACIDE ZOLÉDRONIQUE MONOHYDRATÉ"
],
"authorisationProcedure": "Procédure décentralisée",
"prescriptionConditions": [
"médicament nécessitant une surveillance particulière pendant le traitement",
"liste I"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": null,
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400930217450"